Complete Filing Data
Fidelity Solana Fund reported Shares Outstanding of 7.78 million shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fidelity Solana Fund did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 |
|---|---|---|
| Profit Loss | -$6.1M | -$161.9K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 |
| Assets Net | $113.9M |
| Unrealized Gain Loss On Investments | |
| Stockholders Equity Period Increase Decrease | |
| Stockholders Equity | $113.9M |
| Retained Earnings Accumulated Deficit | -$6.1M |
| Liabilities | $0.00 |
| Gain Loss On Investments | |
| Common Stock Value | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | |
| Assets | $113.9M |
| Non Investment Assets Less Non Investment Liabilities Percent Of Net Assets | $0.00 |
| Non Investment Assets Less Non Investment Liabilities | $0.00 |
| Investment Owned Percent Of Net Assets | $1.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 |
|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | |
| Assets Net | $4.8M | |
| Unrealized Gain Loss On Investments | -$6.4M | -$161.9K |
| Stockholders Equity Period Increase Decrease | $113.9M | $4.8M |
| Stockholders Equity | $4.8M | |
| Retained Earnings Accumulated Deficit | -$161.9K | |
| Liabilities | $0.00 | |
| Gain Loss On Investments | -$6.4M | -$161.9K |
| Common Stock Value | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $0.00 | $0.00 |
| Assets | $4.8M | |
| Non Investment Assets Less Non Investment Liabilities Percent Of Net Assets | ||
| Non Investment Assets Less Non Investment Liabilities | ||
| Investment Owned Percent Of Net Assets |
Cash Flow Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 |
|---|---|---|
| Proceeds From Issuance Of Common Stock | $73.9M | $5.0M |
| Payments For Purchase Of Investment Operating Activity | $73.9M | $5.0M |
| Net Cash Provided By Used In Operating Activities | -$73.9M | -$5.0M |
| Net Cash Provided By Used In Financing Activities | $73.9M | $5.0M |
| Increase Decrease In Operating Assets | -$6.1M | -$161.9K |
| Payments For Repurchase Of Common Stock | $25.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Shares Outstanding | 7.8M |
| Net Asset Value Per Share | $14.66 |
| Common Stock Shares Outstanding | 7.8M |
| Common Stock Shares Issued | 7.8M |
| Common Stock Par Or Stated Value Per Share | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Shares Outstanding | 200.0K |
| Net Asset Value Per Share | $24.19 |
| Common Stock Shares Outstanding | 200.0K |
| Common Stock Shares Issued | 200.0K |
| Common Stock Par Or Stated Value Per Share | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stock Repurchased And Retired During Period Shares | |
| Stock Redeemed Or Called During Period Value | |
| Stock Issued During Period Value New Issues | |
| Stock Issued During Period Shares Period Increase Decrease | |
| Stock Issued During Period Shares New Issues | |
| Realized Investment Gains Losses | |
| Net Investment Income | |
| Investment Owned At Cost | $120.3M |
| Investment Income Net | |
| Investment Income Interest | |
| Investment Company Increase Decrease From Share Transaction | |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | |
| Additional Paid In Capital | $120.0M |
| Staking Rewards Received | |
| Sponsor Fees | |
| Other Significant Noncash Transaction Value Of Consideration Received1 | |
| Operating Costs And Expenses | |
| Investment Owned At Fair Value | $113.9M |
| Investment Company Expense Offset Arrangement |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 |
|---|---|---|
| Stock Repurchased And Retired During Period Shares | 1.00 | 1.00 |
| Stock Redeemed Or Called During Period Value | $0.00 | $25.00 |
| Stock Issued During Period Value New Issues | $120.0M | $5.0M |
| Stock Issued During Period Shares Period Increase Decrease | 7.8M | 200.0K |
| Stock Issued During Period Shares New Issues | 7.8M | 200.0K |
| Realized Investment Gains Losses | $0.00 | $0.00 |
| Net Investment Income | $299.0K | $0.00 |
| Investment Owned At Cost | $5.0M | |
| Investment Income Net | $299.0K | $0.00 |
| Investment Income Interest | $299.0K | $0.00 |
| Investment Company Increase Decrease From Share Transaction | $120.0M | $5.0M |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $0.00 | $0.00 |
| Additional Paid In Capital | $5.0M | |
| Staking Rewards Received | $299.0K | |
| Sponsor Fees | $16.0K | |
| Other Significant Noncash Transaction Value Of Consideration Received1 | $46.1M | |
| Operating Costs And Expenses | $16.0K | |
| Investment Owned At Fair Value | ||
| Investment Company Expense Offset Arrangement | $16.0K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.